Eradication of Helicobacter

Study of probiotic and simvastatin additive effect on Helicobacter eradication rate

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180130038566N1

Enrollment

160

Registered

2018-05-13

Start date

2017-03-21

Completion date

Unknown

Last updated

2018-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Helicobacter pylori. Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhere

Interventions

Intervention 1: Simvastatin 10 mg - Sobhan Iran Co. - Required quantity or amount 560. Intervention 2: Simvastatin 20 mg - Sobhan Iran Co. - Required amount or amount of 560. Intervention 3: Daily Pro

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Is over 18 years old. Is satisfied. In terms of Helicobacter pylori, it has not been treated until now.

Exclusion criteria

Exclusion criteria: Dissatisfaction. Have a history of recent antibiotic intake. Contra has indications of receiving probiotic or simvastatin, or when it comes to drug use during drug use. alcohol consumption. smoking.

Design outcomes

Primary

Measure	Time frame
Eradication rate of Helicobacter pylori. Timepoint: Patients are treated for two weeks, after which treatment is discontinued and four weeks after completion of the treatment, a fecal antigen test for eradication of Helicobacter pylori infection is examined. Method of measurement: Measurement of Helicobacter pylori in Ahvaz Imam Khomeini Hospital Laboratory.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAbazar Parsi

Ahvaz University of Medical Sciences

dr_abazar_parsi@yahoo.com+98 61 3311

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026